glp 1 taken off market Poll: in 8 Adults Say They've a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease GLP-1 use peaks in middle

What's often left out of the headlines: most participants started the trials clinically obese and ended them still clinically obese, just less so

Yes, you can absolutely take them together

After 40 weeks, tirzepatide significantly outperformed placebo in both glycemic control and weight loss

Most patients (93%) tolerate side effects well enough to continue treatment

This is a perfect example on how obesity and weight gain are not lifestyle issues nor lack of willpower, says Rocio Salas-Whalen, MD, is a board-certified endocrinologist specializing in obesity medicine and author of Weightless: A Doctors Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve

However, almost as quickly, scientific criticism of the study also began rolling in